Literature DB >> 12531551

Glucosylceramide synthase and apoptosis.

Richard J Bleicher1, Myles C Cabot.   

Abstract

Glucosylceramide synthase (GCS) is an enzyme inherent to ceramide metabolism. The enzyme catalyzes the transfer of glucose to ceramide, the first committed step in glycolipid biosynthesis. Known for many years as a branch point enzyme directing synthesis of cerebrosides and gangliosides, GCS has recently been implicated in the cytotoxic response of cancer cells to chemotherapy. With ceramide now occupying a central role in the signaling mechanisms of apoptosis, the position of GCS as sentry is perhaps not unexpected. In particular, it has been recognized that the toxic response of cells to chemotherapy is impaired when GCS activity is elevated and heightened when GCS activity is blocked. Herein we review the control points of ceramide metabolism with special regard to GCS and the cytotoxic response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12531551     DOI: 10.1016/s1388-1981(02)00338-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

1.  1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation.

Authors:  Teng Yu; Jinchao Li; Ying Qiu; Hui Sun
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

2.  Glucosylceramide synthesis inhibition affects cell cycle progression, membrane trafficking, and stage differentiation in Giardia lamblia.

Authors:  Sasa Stefanić; Cornelia Spycher; Laura Morf; Gemma Fabriàs; Josefina Casas; Elisabeth Schraner; Peter Wild; Adrian B Hehl; Sabrina Sonda
Journal:  J Lipid Res       Date:  2010-03-24       Impact factor: 5.922

Review 3.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

4.  Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches.

Authors:  Jacqueline V Chapman; Valérie Gouazé-Andersson; Maria C Messner; Margaret Flowers; Ramin Karimi; Mark Kester; Brian M Barth; Xin Liu; Yong-Yu Liu; Armando E Giuliano; Myles C Cabot
Journal:  Biochem Pharmacol       Date:  2010-04-10       Impact factor: 5.858

5.  Differentiation and Quantification of Diastereomeric Pairs of Glycosphingolipids Using Gas-Phase Ion Chemistry.

Authors:  Hsi-Chun Chao; Scott A McLuckey
Journal:  Anal Chem       Date:  2020-09-18       Impact factor: 6.986

6.  DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells.

Authors:  Teka-Ann S Haynes; Valery Filippov; Maria Filippova; Jun Yang; Kangling Zhang; Penelope J Duerksen-Hughes
Journal:  Biochim Biophys Acta       Date:  2012-02-11

7.  Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival.

Authors:  S Wotton; A Terry; A Kilbey; A Jenkins; P Herzyk; E Cameron; J C Neil
Journal:  Oncogene       Date:  2008-06-16       Impact factor: 9.867

8.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

9.  Ceramide--antiestrogen nanoliposomal combinations--novel impact of hormonal therapy in hormone-insensitive breast cancer.

Authors:  Samy A F Morad; Jonathan C Levin; Sriram S Shanmugavelandy; Mark Kester; Gemma Fabrias; Carmen Bedia; Myles C Cabot
Journal:  Mol Cancer Ther       Date:  2012-09-07       Impact factor: 6.261

10.  Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53.

Authors:  Samy A F Morad; James P Madigan; Jonathan C Levin; Noha Abdelmageed; Ramin Karimi; Daniel W Rosenberg; Mark Kester; Sriram S Shanmugavelandy; Myles C Cabot
Journal:  Biochem Pharmacol       Date:  2013-01-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.